OptiBiotix Health Plc
Consumer study of LPLDL® in Cholbiome® products
SPONSORED ARTICLE
By Elric Langton | 1 February 2022
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, blood pressure, diabetes, anno…